Concord Healthcare Grp Co Ltd (2453.HK)

HKD 13.74

(-2.69%)

EBITDA Summary of Concord Healthcare Grp Co Ltd

  • Concord Healthcare Grp Co Ltd's latest annual EBITDA in 2023 was -172.57 Million CNY , up 41.5% from previous year.
  • Concord Healthcare Grp Co Ltd's latest quarterly EBITDA in 2024 Q2 was -50.55 Million HKD , up 0.15% from previous quarter.
  • Concord Healthcare Grp Co Ltd reported an annual EBITDA of -224.64 Million CNY in 2022, down -15.83% from previous year.
  • Concord Healthcare Grp Co Ltd reported an annual EBITDA of -287.01 Million CNY in 2021, down -60.78% from previous year.
  • Concord Healthcare Grp Co Ltd reported a quarterly EBITDA of -50.55 Million HKD for 2024 Q2, up 0.15% from previous quarter.
  • Concord Healthcare Grp Co Ltd reported a quarterly EBITDA of -105.28 Million HKD for 2023 Q2, down -70.8% from previous quarter.

Annual EBITDA Chart of Concord Healthcare Grp Co Ltd (2023 - 2019)

Historical Annual EBITDA of Concord Healthcare Grp Co Ltd (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -172.57 Million CNY 41.5%
2022 -224.64 Million CNY -15.83%
2021 -287.01 Million CNY -60.78%
2020 -190.4 Million CNY -116.01%
2019 -95.48 Million HKD 0.0%

Peer EBITDA Comparison of Concord Healthcare Grp Co Ltd

Name EBITDA EBITDA Difference
Aidigong Maternal & Child Health Limited 68.84 Million HKD 350.667%
UMP Healthcare Holdings Limited 161.98 Million HKD 206.542%
Human Health Holdings Limited 104.06 Million HKD 265.839%
EuroEyes International Eye Clinic Limited 292.1 Million HKD 159.081%
Kato (Hong Kong) Holdings Limited 133.61 Million HKD 229.165%
Bamboos Health Care Holdings Limited 52.75 Million HKD 427.114%
Beijing Health (Holdings) Limited -44.19 Million HKD -290.53%
C-MER Eye Care Holdings Limited 359.88 Million HKD 147.954%
Town Health International Medical Group Limited 53.5 Million HKD 422.572%
Medicskin Holdings Limited 6.77 Million HKD 2646.916%
Hang Chi Holdings Limited 81.58 Million HKD 311.528%